RxDoctor Payments Data

Avi Landman, MD

Neurology · Kissimmee, FLNPI 1174082002

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $24,888 of the $36,200 with a category attached, or 68.7%. Amgen accounts for 85.3% of it on its own, with 21 other manufacturers making up the rest. 2025 is the largest year on record at $35,800, more than ten times the $31 reported in 2020.

$36,200in general payments, 2019–2025

Across 112 payments — averaging $323.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$31K
  • Grifols Shared Services North America, Inc.$3K
  • Janssen Scientific Affairs, LLC$504
  • AbbVie$338
  • Averitas Pharma Inc.$246
  • Argenx US, Inc.$237
  • plus $913 from 16 others

What the payments were for

  • Consulting fees$4,68813%
  • Speaking & faculty fees$24,88869%
  • Travel & lodging$3,2649%
  • Food & beverage$3,2559%
  • Education$1070%

General payments by program year

20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$36,200 in reported general payments places this provider in the 85th percentile of 1,434 neurology providers in Florida.

See all neurology providers in Florida →

Medicare billing

Part B allowed, 2024
$11,912
Medicare patients
60
Services billed
108

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other neurology in Kissimmee

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →